Journey Medical (DERM) EBIT Margin (2020 - 2026)

Journey Medical (DERM) posted EBIT Margin of 9.37% for Q1 2026, down 240.14% on a QoQ basis from 2.76% in Q4 2025, and up 1593.0% year-over-year from 0.55% in Q1 2025.

Journey Medical (DERM) EBIT Margin (2020 - 2026) Analysis & Trends

Journey Medical's EBIT Margin history runs 7 years deep, the most recent figure standing at 9.37% for Q1 2026.

  • Quarterly EBIT Margin rose 1593.0% year-over-year to 9.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.9% (up 261.0% YoY) and the FY2025 annual result came in at 13.21%, up 1160.0% from the prior year.
  • EBIT Margin was 9.37% for Q1 2026 at Journey Medical, down from 2.76% in the prior quarter.
  • Across five years, EBIT Margin topped out at 49.93% in Q3 2023 and bottomed at 78.59% in Q1 2023.
  • A 5-year average of 24.55% and a median of 19.7% in 2024 frame the typical range for EBIT Margin.
  • Peak annual rise in EBIT Margin reached 10883 bps in 2023, while the deepest fall reached 7432 bps in 2023.
  • Journey Medical's EBIT Margin stood at 62.78% in 2022, then surged by 78 bps to 13.79% in 2023, then soared by 228 bps to 17.7% in 2024, then slumped by 116 bps to 2.76% in 2025, then slumped by 240 bps to 9.37% in 2026.
  • Business Quant data shows DERM's EBIT Margin at 9.37% in Q1 2026, 2.76% in Q4 2025, and 8.98% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 Journey Medical 179.67 Mn 152.45 Mn 9.70 Mn -9.37%

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.37%
Dec 31, 2025 -2.76%
Sep 30, 2025 -8.98%
Jun 30, 2025 -19.16%
Mar 31, 2025 -25.30%
Dec 31, 2024 17.70%
Sep 30, 2024 -19.78%
Jun 30, 2024 -19.70%
Mar 31, 2024 -77.44%
Dec 31, 2023 -13.79%
Sep 30, 2023 49.93%
Jun 30, 2023 -45.12%
Mar 31, 2023 -78.59%
Dec 31, 2022 -62.78%
Sep 30, 2022 -58.90%
Jun 30, 2022 -39.05%
Mar 31, 2022 -4.27%
Dec 31, 2021 -51.70%
Sep 30, 2021 -64.49%
Jun 30, 2021 -90.02%